Growth Inhibition of Triple-Negative Breast Cancer: The Role of Spatiotemporal Delivery of Neoadjuvant Doxorubicin and Cisplatin
Combinations of platinum-based compounds with doxorubicin in free and/or in liposomal form for improved safety are currently being evaluated in the neoadjuvant setting on patients with advanced triple-negative breast cancer (TNBC). However, TNBC may likely be driven by chemotherapy-resistant cells....
Gardado en:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2021-10-01
|
| Series: | Pharmaceuticals |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/1424-8247/14/10/1035 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|